See All Slides - tctmd.com

Slides

Presentation TCT 2025

TCT 450: Real-Time Explainable AI in PCI: A Systematic Review of Imaging and Guidance Applications (2020–2025)

Presenter: Ajavindu C N

October 27, 2025

Presentation TCT 2025

Renal Denervation is FDA Approved - Will it Ever Be First Line Therapy?

Presenter: David P. Lee

October 27, 2025

Presentation TCT 2025

TCT 1339: Percutaneous Resolution of Right-to-Left Shunt in a Post-Aortic Repair Patient: A Case of Complex PFO Closure in the Setting of Pericardial Effusion

Presenter: Rodolfo Alves Lopes

October 27, 2025

Presentation TCT 2025

My Tips and Tricks for Prevention and Management of mTEER Complications

Presenter: Jacob M. Mishell

October 27, 2025

Presentation TCT 2025

TCT 589: Same Day Discharge with the Symplicity Renal Denervation System: Outcomes from the Real World Global Symplicity Registry DEFINE

Presenter: Joachim Weil

October 27, 2025

Presentation TCT 2025

Where Do We See Renal Denervation in the Hypertension Pathway, Now and in Five Years?

Presenter: David E. Kandzari

October 27, 2025

Presentation TCT 2025

Left Ventricular Reconstruction Therapies: Historical Perspectives From Surgical Approaches and Trials

Presenter: Eric Jose Velazquez

October 27, 2025

Presentation TCT 2025

Featured Clinical Research: Aortic Valve Area Reduction: A Novel Concept to Quantify Aortic Stenosis Severity

Presenter: Miho Fukui

October 27, 2025

Presentation TCT 2025

TCT 838: Natural History and Outcomes of Early Aortic Valve Replacement versus Conservative Management in Patients with Asymptomatic Severe Aortic Stenosis: A Meta-Analysis

Presenter: Justin Huang

October 27, 2025

Presentation TCT 2025

Long Term Clinical Outcomes in Patients Treated with the Bioadaptor Compared with a Contemporary Drug Eluting Stent: The INFINITY-SWEDEHEART Randomized Trial

Presenter: David Erlinge

October 27, 2025

Advertisement

Slides

TCT 450: Real-Time Explainable AI in PCI: A Systematic Review of Imaging and Guidance Applications (2020–2025)

Renal Denervation is FDA Approved - Will it Ever Be First Line Therapy?

TCT 1339: Percutaneous Resolution of Right-to-Left Shunt in a Post-Aortic Repair Patient: A Case of Complex PFO Closure in the Setting of Pericardial Effusion

My Tips and Tricks for Prevention and Management of mTEER Complications

TCT 589: Same Day Discharge with the Symplicity Renal Denervation System: Outcomes from the Real World Global Symplicity Registry DEFINE

Where Do We See Renal Denervation in the Hypertension Pathway, Now and in Five Years?

Left Ventricular Reconstruction Therapies: Historical Perspectives From Surgical Approaches and Trials

Featured Clinical Research: Aortic Valve Area Reduction: A Novel Concept to Quantify Aortic Stenosis Severity

TCT 838: Natural History and Outcomes of Early Aortic Valve Replacement versus Conservative Management in Patients with Asymptomatic Severe Aortic Stenosis: A Meta-Analysis

Long Term Clinical Outcomes in Patients Treated with the Bioadaptor Compared with a Contemporary Drug Eluting Stent: The INFINITY-SWEDEHEART Randomized Trial

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content